194. Antimicrobial Susceptibility Data of Staphylococcus lugdunensis After the Implementation of Rapid Molecular Blood Culture Diagnostics (Verigene® Gram-Positive Blood Culture Nucleic Acid Test)

MLA

Kristin Constance, et al. “194. Antimicrobial Susceptibility Data of Staphylococcus Lugdunensis After the Implementation of Rapid Molecular Blood Culture Diagnostics (Verigene® Gram-Positive Blood Culture Nucleic Acid Test).” Open Forum Infectious Diseases, vol. 8, Nov. 2021, pp. S204–05. EBSCOhost, https://doi.org/10.1093/ofid/ofab466.396.

APA

Kristin Constance, Alauna Hunt, Sam Karimaghaei, Juliet Chijioke, Violeta Chavez, Audrey Wanger, & Nigo Masayuki. (2021). 194. Antimicrobial Susceptibility Data of Staphylococcus lugdunensis After the Implementation of Rapid Molecular Blood Culture Diagnostics (Verigene® Gram-Positive Blood Culture Nucleic Acid Test). Open Forum Infectious Diseases, 8, S204–S205. https://doi.org/10.1093/ofid/ofab466.396

Chicago

Kristin Constance, Alauna Hunt, Sam Karimaghaei, Juliet Chijioke, Violeta Chavez, Audrey Wanger, and Nigo Masayuki. 2021. “194. Antimicrobial Susceptibility Data of Staphylococcus Lugdunensis After the Implementation of Rapid Molecular Blood Culture Diagnostics (Verigene® Gram-Positive Blood Culture Nucleic Acid Test).” Open Forum Infectious Diseases 8 (November): S204–5. doi:10.1093/ofid/ofab466.396.